PMP22 and hepatocellular carcinoma: Moreover, high expression of PMP22 negatively correlates with a decrease in relapse-free survival across HCC patients significantly, while conversely in GSC expression, indicating that the aberrant PMP22 and GSC-gene signatures are the important events in HCC progression (Fig. 6E).